Shares Of Glp Now Overbought

In trading on Thursday, shares of Global Partners LP (NYSE: GLP) entered into overbought territory, changing hands as high as $22.75 per share. We define overbought territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100.

BING NEWS:
  • Lilly and Novo Went Head-to-Head Over Weight-Loss Drugs in 2024. There’s a Clear Winner.
    It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
    12/31/2024 - 2:02 am | View Link
  • Ozempic economics: How GLP-1s will disrupt the economy in 2025
    A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and what its unintended consequences could be.
    12/30/2024 - 10:00 pm | View Link
  • 5 Ozempic updates
    Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
    12/30/2024 - 7:04 am | View Link
  • Amylyx Partners with Gubra for GLP-1 Antagonist
    Amylyx Pharmaceuticals Inc ( (AMLX) ) has provided an update.
    12/30/2024 - 12:18 am | View Link
  • 2025 forecast: After Novo, Lilly expansion sprees, 'positive signals' emerge around future supply of GLP-1 drugs
    Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive signals” are emerging when it comes to the consistent supply of GLP-1 medicines ...
    12/29/2024 - 11:00 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News